北美外泌体诊断和治疗市场预测至 2027 年 - COVID-19 影响和应用区域分析（诊断和治疗）；产品（仪器、试剂和软件）；最终用户（癌症研究所、医院、诊断中心和其他最终用户）和国家/地区
No. of Pages: 82 | Report Code: TIPRE00010411 | Category: Life Sciences
No. of Pages: 82 | Report Code: TIPRE00010411 | Category: Life Sciences
北美外泌体诊断和治疗市场预计将从 2019 年的 17,578.32 万美元增长到 2027 年的 154,116.95 万美元。这意味着从 2020 年到 2027 年的复合年增长率为 32.5% 2027年。
预计该地区市场的增长由于使用外泌体作为癌症诊断生物标志物的需求增加、癌症患病率不断增加、人口老龄化和生活方式的改变，该领域的增长。此外，强大的产品线、主要参与者的存在以及完善的监管政策预计将在预测期内推动北美外泌体诊断和治疗市场的发展。
过去几年，美国外泌体诊断和治疗市场快速增长，预计在预测期内将引领北美市场。目前，外泌体在获得干细胞治疗效果方面正在迅速获得动力。此外，它们还有望用作非侵入性测试中的生物标志物、药物输送载体以及药妆产品中的活性剂。制造技术方面的投资也有所增加，以支持临床级干细胞外泌体的生产。例如，2017 年，RoosterBio 和 Exopharm 合作开展了干细胞外显子项目。该项目的目标是将源自成体干细胞的治疗性细胞外外泌体开发到临床实践中。该行业的许可活动也有所增加，为美国市场的增长提供了有利可图的机会。此外，2014 年，Capricor Therapeutics 与 Cedars-Sinai 医疗中心增加了七项新的专利申请，涉及与心脏圈衍生细胞 (CDC) 和 CDC 衍生的细胞外囊泡（包括外泌体）相关的技术。
北美外泌体诊断和治疗市场 - 按应用
北美外泌体诊断和治疗市场 - 按产品
北美外泌体诊断和治疗市场 - 按最终用户
北美外泌体诊断和治疗市场 - 按国家
公司简介
Strategic insights for North America Exosome Diagnostic and Therapeutic involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 17,578.32 thousand |
| Market Size by 2027 | US$ 154,116.95 thousand |
| Global CAGR (2020 - 2027) | 32.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 应用
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Exosome Diagnostic and Therapeutic refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Exosome Diagnostic and Therapeutic Market
The North America Exosome Diagnostic and Therapeutic Market is valued at US$ 17,578.32 thousand in 2019, it is projected to reach US$ 154,116.95 thousand by 2027.
As per our report North America Exosome Diagnostic and Therapeutic Market, the market size is valued at US$ 17,578.32 thousand in 2019, projecting it to reach US$ 154,116.95 thousand by 2027. This translates to a CAGR of approximately 32.5% during the forecast period.
The North America Exosome Diagnostic and Therapeutic Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Exosome Diagnostic and Therapeutic Market report:
The North America Exosome Diagnostic and Therapeutic Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Exosome Diagnostic and Therapeutic Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Exosome Diagnostic and Therapeutic Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Exosome Diagnostic and Therapeutic Market
